NCT04369456View on ClinicalTrials.gov

Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

April 21, 2021

Study Completion Date

April 21, 2021

Conditions

Kidney Transplant; ComplicationsCoronavirus Infection

Interventions

OTHER

blood sample

a blood sample is taken on Covid-19 kidney transplant patients with moderate symptoms

Trial Locations (7)

13000

APHM, Marseille

34000

Montpellier University Hospital, Montpellier

42000

Saint Etienne University Hospital, Saint-Etienne

67000

Strasbourg Univeristy Hospital, Strasbourg

69000

Lyon Univerity Hospital, Lyon

75000

APHP, Paris

06000

University Nice Hospital, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04369456 - Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients | Biotech Hunter | Biotech Hunter